You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 10, October 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vascular Endothelial Cell Growth Inhibitor of Normal and Pathologic Human Vitreous

Bernard Jacobson, PhD; Prasanta K. Basu, MB, DOMS; Syed M. Hasany, MSc

Arch Ophthalmol. 1984;102(10):1543-1545.


Abstract

• Normal and pathologic human vitreous have been analyzed for the presence of a low—molecular weight inhibitor of aortic endothelial cell proliferation. Vitreous was subjected to gel chromatography and the material appearing in the retarded volume (<13,000 daltons) was tested for its ability to inhibit tritiated thymidine incorporation into DNA by calf aortic endothelial cells. Depending on the sample of vitreous analyzed, one or more fractions showing inhibitory activity were identified in each case.



Author Affiliations

From the Department of Fine Structure Research, Boston Biomedical Research Institute, and the Department of Ophthalmology, Harvard Medical School, Boston (Dr Jacobson), and the Department of Ophthalmology, University of Toronto (Dr Basu and Mr Hasany).


Footnotes

Accepted for publication May 11, 1984.

Reprint requests to Department of Fine Structure Research, Boston Biomedical Research Institute, 20 Staniford St, Boston, MA 02114 (Dr Jacobson).

This study was supported by National Institutes of Health grant EY-04393 (Dr Jacobson) and the Lions International District A-16 Ophthalmological Research Foundation, The Canadian National Institute for the Blind out of the E. A. Baker Foundation for the Prevention of Blindness, and the Medical Research Council of Canada, Toronto (Dr Basu).

C. Mortimer, MD, M. Mandelcorn, MD, and M. Shusterman, MD, supplied the vitrectomy samples, and the Eye Bank of Canada, Ontario, supplied the cadaver vitreous. Margaret O'Neil performed the gel chromatography and testing of vitreous fractions on endothelial cell growth.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration
Bhutto et al.
IOVS 2004;45:1544-1552.
ABSTRACT | FULL TEXT  

Expression and Localization of Tenomodulin, a Transmembrane Type Chondromodulin-I-Related Angiogenesis Inhibitor, in Mouse Eyes
Oshima et al.
IOVS 2003;44:1814-1823.
ABSTRACT | FULL TEXT  

Down-regulation of Vascular Endothelial Growth Factor and Up-regulation of Pigment Epithelium-derived Factor. A POSSIBLE MECHANISM FOR THE ANTI-ANGIOGENIC ACTIVITY OF PLASMINOGEN KRINGLE 5
Gao et al.
J. Biol. Chem. 2002;277:9492-9497.
ABSTRACT | FULL TEXT  

Expression and Localization of Angiogenic Inhibitory Factor, Chondromodulin-I, in Adult Rat Eye
Funaki et al.
IOVS 2001;42:1193-1200.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.